Rating
Buy
Price target
$195
Previous
$195
Implied upside
+28%

Mizuho analyst Gregg Moskowitz reiterated an Outperform rating and $195.00 price target on Palantir (NASDAQ: PLTR).

“We recently hosted meetings with Peter Czimback, Independent Advisor to the PLTR CFO and former VP of Experience Innovation at Aramark (a PLTR customer), along with a current PLTR customer in the Architectural, Engineering and Construction vertical.

During our discussions, the executives highlighted compelling deployment use cases, PLTR’s differentiated bespoke approach to enterprise transformation, and the absence of any comparable alternative.

We reiterate our view that PLTR is in a category of one, delivering total revenue growth, acceleration, and margin expansion at scale that is unlike anything else in software.

We also remain bullish on a surging US Commercial business fueled by rising enterprise adoption of AIP and growing urgency around operationalizing AI.

And more broadly, we remain steadfast in our view that PLTR is increasingly well-positioned to benefit from long-term trends in AI, government digital transformation, and industrial modernization.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.